{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:15:40Z","timestamp":1793312140967,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02235-y","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:55:46Z","timestamp":1785304546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fatty acids metabolic reprogramming and tumor microenvironment in pancreatic cancer: targeting pathways"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6048-5625","authenticated-orcid":false,"given":"Bassant","family":"Ehab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8008-9966","authenticated-orcid":false,"given":"Ekram","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"8","key":"2235_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/jamaoncol.2024.1930","volume":"10","author":"AL Blackford","year":"2024","unstructured":"Blackford AL, Canto MI, Dbouk M, Hruban RH, Katona BW, Chak A, et al. Pancreatic cancer surveillance and survival of high-risk individuals. JAMA Oncol. 2024;10(8):1087\u201396. https:\/\/doi.org\/10.1001\/jamaoncol.2024.1930.","journal-title":"JAMA Oncol"},{"issue":"10242","key":"2235_CR2","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(20)30974-0.","journal-title":"Lancet"},{"issue":"1","key":"2235_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10\u201327. https:\/\/doi.org\/10.14740\/wjon1166.","journal-title":"World J Oncol"},{"issue":"4","key":"2235_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","volume":"393","author":"S Iodice","year":"2008","unstructured":"Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008;393(4):535\u201345. https:\/\/doi.org\/10.1007\/s00423-007-0266-2.","journal-title":"Langenbecks Arch Surg"},{"issue":"7","key":"2235_CR5","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/annonc\/mdr541","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol. 2012;23(7):1880\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdr541.","journal-title":"Ann Oncol"},{"issue":"11","key":"2235_CR6","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley R, Ansary-Moghaddam A, Berrington de Gonz\u00e1lez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92(11):2076\u201383. https:\/\/doi.org\/10.1038\/sj.bjc.6602619.","journal-title":"Br J Cancer"},{"issue":"4","key":"2235_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/annonc\/mdr398","volume":"23","author":"D Aune","year":"2012","unstructured":"Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012;23(4):843\u201352. https:\/\/doi.org\/10.1093\/annonc\/mdr398.","journal-title":"Ann Oncol"},{"issue":"4","key":"2235_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(4):439\u201357. https:\/\/doi.org\/10.6004\/jnccn.2021.0017.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"2235_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/ijo.2022.5383","volume":"61","author":"M Zuz\u010d\u00e1k","year":"2022","unstructured":"Zuz\u010d\u00e1k M, Trnka J. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). Int J Oncol. 2022;61(2):93. https:\/\/doi.org\/10.3892\/ijo.2022.5383.","journal-title":"Int J Oncol"},{"issue":"5","key":"2235_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"11","key":"2235_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732\u201349. https:\/\/doi.org\/10.1038\/nrc.2016.89.","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"2235_CR12","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","volume":"279","author":"CR Santos","year":"2012","unstructured":"Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012;279(15):2610\u201323.","journal-title":"FEBS J"},{"issue":"22","key":"2235_CR13","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1073\/pnas.1307237110","volume":"110","author":"JJ Kamphorst","year":"2013","unstructured":"Kamphorst JJ, Cross JR, Fan J, de Stanchina E, Mathew R, White EP, et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci USA. 2013;110(22):8882\u20137. https:\/\/doi.org\/10.1073\/pnas.1307237110.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2235_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","volume":"244","author":"JD McGarry","year":"1997","unstructured":"McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997;244(1):1\u201314.","journal-title":"Eur J Biochem"},{"issue":"5","key":"2235_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1139\/cjpp-2020-0165","volume":"99","author":"X Luo","year":"2021","unstructured":"Luo X, Sun D, Wang Y, Zhang F, Wang Y. Cpt1a promoted ROS-induced oxidative stress and inflammation in liver injury via the Nrf2\/HO-1 and NLRP3 inflammasome signaling pathway. Can J Physiol Pharmacol. 2021;99(5):468\u201377. https:\/\/doi.org\/10.1139\/cjpp-2020-0165.","journal-title":"Can J Physiol Pharmacol"},{"issue":"6127","key":"2235_CR16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1126\/science.1230184","volume":"339","author":"ML Suv\u00e0","year":"2013","unstructured":"Suv\u00e0 ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Science. 2013;339(6127):1567\u201370. https:\/\/doi.org\/10.1126\/science.1230184.","journal-title":"Science"},{"issue":"1","key":"2235_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-026-00427-2","volume":"7","author":"M Yu","year":"2026","unstructured":"Yu M, Yang D, Chen X, Yang Y, Zhang B, Jiang X, et al. Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. Mol Biomed. 2026;7(1):25. https:\/\/doi.org\/10.1186\/s43556-026-00427-2.","journal-title":"Mol Biomed"},{"issue":"1","key":"2235_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-024-02218-1","volume":"24","author":"Q Ma","year":"2025","unstructured":"Ma Q, Zhang W, Wu K, Shi L. The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy. Mol Cancer. 2025;24(1):14. https:\/\/doi.org\/10.1186\/s12943-024-02218-1.","journal-title":"Mol Cancer"},{"issue":"21","key":"2235_CR19","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.3390\/cancers13215481","volume":"13","author":"S Bansod","year":"2021","unstructured":"Bansod S, Dodhiawala PB, Lim KH. Oncogenic KRAS-induced feedback inflammatory signaling in pancreatic cancer: an overview and new therapeutic opportunities. Cancers (Basel). 2021;13(21):5481. https:\/\/doi.org\/10.3390\/cancers13215481.","journal-title":"Cancers (Basel)"},{"issue":"7629","key":"2235_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nature20132","volume":"539","author":"F Kottakis","year":"2016","unstructured":"Kottakis F, Nicolay BN, Roumane A, Karnik R, Gu H, Nagle JM, et al. LKB1 loss links serine metabolism to DNA methylation and tumorigenesis. Nature. 2016;539(7629):390\u20135. https:\/\/doi.org\/10.1038\/nature20132.","journal-title":"Nature"},{"issue":"3","key":"2235_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","volume":"75","author":"JJ Kamphorst","year":"2015","unstructured":"Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75(3):544\u201353. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2211.","journal-title":"Cancer Res"},{"issue":"10","key":"2235_CR22","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.3390\/ijms22105070","volume":"22","author":"IJ Muyinda","year":"2021","unstructured":"Muyinda IJ, Park JG, Jang EJ, Yoo BC. KRAS, a prime mediator in pancreatic lipid synthesis through extra mitochondrial glutamine and citrate metabolism. Int J Mol Sci. 2021;22(10):5070. https:\/\/doi.org\/10.3390\/ijms22105070.","journal-title":"Int J Mol Sci"},{"key":"2235_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2026.03.004","author":"A Costamagna","year":"2026","unstructured":"Costamagna A, Milan G, De Santis MC, Carrer A, Martini M. Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. Trends Endocrinol Metab. 2026. https:\/\/doi.org\/10.1016\/j.tem.2026.03.004.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2235_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008;8(3):224\u201336. https:\/\/doi.org\/10.1016\/j.cmet.2008.07.007.","journal-title":"Cell Metab"},{"issue":"4","key":"2235_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"G Hatzivassiliou","year":"2005","unstructured":"Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005;8(4):311\u201321. https:\/\/doi.org\/10.1016\/j.ccr.2005.09.008.","journal-title":"Cancer Cell"},{"issue":"2","key":"2235_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1389450115666141224125117","volume":"16","author":"AD Khwairakpam","year":"2015","unstructured":"Khwairakpam AD, Shyamananda MS, Sailo BL, Rathnakaram SR, Padmavathi G, Kotoky J, et al. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment. Curr Drug Targets. 2015;16(2):156\u201363. https:\/\/doi.org\/10.2174\/1389450115666141224125117.","journal-title":"Curr Drug Targets"},{"issue":"401","key":"2235_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aac5124","volume":"8","author":"JW Haskins","year":"2015","unstructured":"Haskins JW, Zhang S, Means RE, Kelleher JK, Cline GW, Canfr\u00e1n-Duque A, et al. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake. Science Signaling. 2015;8(401):ra111. https:\/\/doi.org\/10.1126\/scisignal.aac5124.","journal-title":"Science Signaling"},{"issue":"2","key":"2235_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","volume":"52","author":"M Chan-Seng-Yue","year":"2020","unstructured":"Chan-Seng-Yue M, Kim JC, Wilson GW, Ng K, Figueroa EF, O\u2019Kane GM, et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat Genet. 2020;52(2):231\u201340. https:\/\/doi.org\/10.1038\/s41588-019-0566-9.","journal-title":"Nat Genet"},{"issue":"17","key":"2235_CR29","doi-asserted-by":"publisher","first-page":"1738440","DOI":"10.3389\/fimmu.2026.1738440","volume":"23","author":"\u00cd Gonz\u00e1lez-Larreategui","year":"2026","unstructured":"Gonz\u00e1lez-Larreategui \u00cd, Vald\u00e9s-Bango Mart\u00edn M, Casacuberta-Serra S, Soucek L. MYC at the tumor-immune interface: mechanisms of immune escape and immunotherapy resistance. Front Immunol. 2026;23(17):1738440. https:\/\/doi.org\/10.3389\/fimmu.2026.1738440.","journal-title":"Front Immunol"},{"issue":"47","key":"2235_CR30","doi-asserted-by":"publisher","first-page":"36267","DOI":"10.1074\/jbc.M110.141606","volume":"285","author":"F Morrish","year":"2010","unstructured":"Morrish F, Noonan J, Perez-Olsen C, Gafken PR, Fitzgibbon M, Kelleher J, et al. Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry. J Biol Chem. 2010;285(47):36267\u201374. https:\/\/doi.org\/10.1074\/jbc.M110.141606.","journal-title":"J Biol Chem"},{"key":"2235_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","volume":"502","author":"J Chen","year":"2021","unstructured":"Chen J, Ding C, Chen Y, Hu W, Yu C, Peng C, et al. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway. Cancer Lett. 2021;502:154\u201365. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.019.","journal-title":"Cancer Lett"},{"issue":"10","key":"2235_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, Metabolism, and Cancer. Cancer Discov. 2015;5(10):1024\u201339. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0507.","journal-title":"Cancer Discov"},{"key":"2235_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2021.100839","volume":"83","author":"RM Loughran","year":"2022","unstructured":"Loughran RM, Emerling BM. Mechanistic roles of mutant p53 governing lipid metabolism. Adv Biol Regul. 2022;83:100839. https:\/\/doi.org\/10.1016\/j.jbior.2021.100839.","journal-title":"Adv Biol Regul"},{"key":"2235_CR34","doi-asserted-by":"publisher","first-page":"1753215","DOI":"10.3389\/fimmu.2026.1753215","volume":"17","author":"L Liang","year":"2026","unstructured":"Liang L, Wang W. The impact of p53 mutation on tumor immune evasion: mechanistic insights and clinical implications. Front Immunol. 2026;17:1753215. https:\/\/doi.org\/10.3389\/fimmu.2026.1753215.","journal-title":"Front Immunol"},{"issue":"1","key":"2235_CR35","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1038\/s41467-021-23902-6","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, Chu B, Yang X, Liu Z, Jin Y, Kon N, et al. iPLA2\u03b2-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Nat Commun. 2021;12(1):3644. https:\/\/doi.org\/10.1038\/s41467-021-23902-6.","journal-title":"Nat Commun"},{"issue":"2","key":"2235_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2012.12.008","volume":"23","author":"DB Shackelford","year":"2013","unstructured":"Shackelford DB, Abt E, Gerken L, Vasquez DS, Seki A, Leblanc M, et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell. 2013;23(2):143\u201358. https:\/\/doi.org\/10.1016\/j.ccr.2012.12.008.","journal-title":"Cancer Cell"},{"key":"2235_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-026-04289-6","author":"I Roy","year":"2026","unstructured":"Roy I, Thakur R. Unravelling the pathogenesis and therapeutic approaches of pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2026. https:\/\/doi.org\/10.1007\/s12094-026-04289-6.","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"2235_CR38","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1021\/acschembio.0c00546","volume":"15","author":"H Karaboga","year":"2020","unstructured":"Karaboga H, Huang W, Srivastava S, Widmann S, Addanki S, Gamage KT, et al. Screening of focused compound library targeting liver X receptors in pancreatic cancer identified ligands with inverse agonist and degrader activity. ACS Chem Biol. 2020;15(11):2916\u201328. https:\/\/doi.org\/10.1021\/acschembio.0c00546.","journal-title":"ACS Chem Biol"},{"key":"2235_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40170-016-0146-8","volume":"4","author":"B Peck","year":"2016","unstructured":"Peck B, Schug ZT, Zhang Q, Dankworth B, Jones DT, Smethurst E, et al. Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments. Cancer Metab. 2016;4:6. https:\/\/doi.org\/10.1186\/s40170-016-0146-8.","journal-title":"Cancer Metab"},{"issue":"4","key":"2235_CR40","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.3390\/cimb46040177","volume":"46","author":"D Stefanoudakis","year":"2024","unstructured":"Stefanoudakis D, Frountzas M, Schizas D, Michalopoulos NV, Drakaki A, Toutouzas KG. Significance of TP53, CDKN2A, SMAD4 and KRAS in pancreatic cancer. Curr Issues Mol Biol. 2024;46(4):2827\u201344. https:\/\/doi.org\/10.3390\/cimb46040177.","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"2235_CR41","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1007\/s13277-015-3047-5","volume":"36","author":"Y Sun","year":"2015","unstructured":"Sun Y, He W, Luo M, Zhou Y, Chang G, Ren W, et al. SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism. Tumour Biol. 2015;36(6):4133\u201341. https:\/\/doi.org\/10.1007\/s13277-015-3047-5.","journal-title":"Tumour Biol"},{"issue":"1\u20132","key":"2235_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11010-009-0154-x","volume":"331","author":"J Ma","year":"2009","unstructured":"Ma J, Sawai H, Ochi N, Matsuo Y, Xu D, Yasuda A, et al. PTEN regulates angiogenesis through PI3K\/Akt\/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem. 2009;331(1\u20132):161\u201371. https:\/\/doi.org\/10.1007\/s11010-009-0154-x.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"2235_CR43","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cac2.12360","volume":"42","author":"X Yin","year":"2022","unstructured":"Yin X, Xu R, Song J, Ruze R, Chen Y, Wang C, et al. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun (Lond). 2022;42(12):1234\u201356. https:\/\/doi.org\/10.1002\/cac2.12360.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"2235_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/157489212799972954","volume":"7","author":"XY Zu","year":"2012","unstructured":"Zu XY, Zhang QH, Liu JH, Cao RX, Zhong J, Yi GH, et al. ATP citrate lyase inhibitors as novel cancer therapeutic agents. Recent Pat Anticancer Drug Discov. 2012;7(2):154\u201367. https:\/\/doi.org\/10.2174\/157489212799972954.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"1","key":"2235_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188837","volume":"1878","author":"W He","year":"2023","unstructured":"He W, Li Q, Li X. Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer. Biochim Biophys Acta Rev Cancer. 2023;1878(1):188837. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188837.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"2235_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7. (Epub 2019 Nov 4).","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2235_CR47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","volume":"33","author":"Z Li","year":"2021","unstructured":"Li Z, Liu H, He J, Wang Z, Yin Z, You G, et al. Acetyl-CoA synthetase 2: a critical linkage in obesity-induced tumorigenesis in myeloma. Cell Metab. 2021;33(1):78-93. e7. https:\/\/doi.org\/10.1016\/j.cmet.2020.12.011.","journal-title":"Cell Metab"},{"issue":"5","key":"2235_CR48","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1158\/0008-5472.CAN-20-1847","volume":"81","author":"KD Miller","year":"2021","unstructured":"Miller KD, Pniewski K, Perry CE, Papp SB, Shaffer JD, Velasco-Silva JN, et al. Targeting ACSS2 with a transition-state mimetic inhibits triple-negative breast cancer growth. Cancer Res. 2021;81(5):1252\u201364. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1847.","journal-title":"Cancer Res"},{"issue":"2","key":"2235_CR49","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/jcp.25954","volume":"233","author":"H Xu","year":"2018","unstructured":"Xu H, Luo J, Ma G, Zhang X, Yao D, Li M, et al. Acyl-CoA synthetase short-chain family member 2 (ACSS2) is regulated by SREBP-1 and plays a role in fatty acid synthesis in caprine mammary epithelial cells. J Cell Physiol. 2018;233(2):1005\u201316. https:\/\/doi.org\/10.1002\/jcp.25954.","journal-title":"J Cell Physiol"},{"issue":"3","key":"2235_CR50","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.celrep.2016.12.055","volume":"18","author":"V Bulusu","year":"2017","unstructured":"Bulusu V, Tumanov S, Michalopoulou E, van den Broek NJ, MacKay G, Nixon C, et al. Acetate recapturing by nuclear acetyl-coa synthetase 2 prevents loss of histone acetylation during oxygen and serum limitation. Cell Rep. 2017;18(3):647\u201358. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.055.","journal-title":"Cell Rep"},{"issue":"7710","key":"2235_CR51","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-018-0201-4","volume":"558","author":"M Hunkeler","year":"2018","unstructured":"Hunkeler M, Hagmann A, Stuttfeld E, Chami M, Guri Y, Stahlberg H, et al. Structural basis for regulation of human acetyl-CoA carboxylase. Nature. 2018;558(7710):470\u20134. https:\/\/doi.org\/10.1038\/s41586-018-0201-4.","journal-title":"Nature"},{"issue":"10","key":"2235_CR52","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/13543784.2019.1657825","volume":"28","author":"L Chen","year":"2019","unstructured":"Chen L, Duan Y, Wei H, Ning H, Bi C, Zhao Y, et al. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1\/2 inhibitors. Expert Opin Investig Drugs. 2019;28(10):917\u201330. https:\/\/doi.org\/10.1080\/13543784.2019.1657825.","journal-title":"Expert Opin Investig Drugs"},{"key":"2235_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.836058","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yu W, Li S, Guo D, He J, Wang Y. Acetyl-CoA carboxylases and diseases. Front Oncol. 2022;12:836058. https:\/\/doi.org\/10.3389\/fonc.2022.836058.","journal-title":"Front Oncol"},{"issue":"7","key":"2235_CR54","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/ijc.32042","volume":"144","author":"C Vernieri","year":"2019","unstructured":"Vernieri C, Pusceddu S, Fuc\u00e0 G, Indelicato P, Centonze G, Castagnoli L, et al. Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs). Int J Cancer. 2019;144(7):1704\u201312. https:\/\/doi.org\/10.1002\/ijc.32042.","journal-title":"Int J Cancer"},{"key":"2235_CR55","doi-asserted-by":"publisher","DOI":"10.2174\/1574892818666230112170003","author":"S Singh","year":"2016","unstructured":"Singh S, Karthikeyan C, Moorthy NSHN. Fatty acid synthase (FASN): a patent review since 2016-present. Recent Pat Anticancer Drug Discov. 2016. https:\/\/doi.org\/10.2174\/1574892818666230112170003.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"9","key":"2235_CR56","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1158\/1055-9965.EPI-09-0144","volume":"18","author":"K Walter","year":"2009","unstructured":"Walter K, Hong SM, Nyhan S, Canto M, Fedarko N, Klein A, et al. Serum fatty acid synthase as a marker of pancreatic neoplasia. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2380\u20135. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-0144.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2235_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.stem.2020.04.002","volume":"27","author":"M Bowers","year":"2020","unstructured":"Bowers M, Liang T, Gonzalez-Bohorquez D, Zocher S, Jaeger BN, Kovacs WJ, et al. FASN-dependent lipid metabolism links neurogenic stem\/progenitor cell activity to learning and memory deficits. Cell Stem Cell. 2020;27(1):98-109.e11. https:\/\/doi.org\/10.1016\/j.stem.2020.04.002.","journal-title":"Cell Stem Cell"},{"issue":"20","key":"2235_CR58","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","volume":"77","author":"S Tadros","year":"2017","unstructured":"Tadros S, Shukla SK, King RJ, Gunda V, Vernucci E, Abrego J, et al. De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer. Cancer Res. 2017;77(20):5503\u201317. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3062.","journal-title":"Cancer Res"},{"issue":"8","key":"2235_CR59","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nrm1174","volume":"4","author":"RB Rawson","year":"2003","unstructured":"Rawson RB. The SREBP pathway\u2013insights from insigs and insects. Nat Rev Mol Cell Biol. 2003;4(8):631\u201340. https:\/\/doi.org\/10.1038\/nrm1174.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2235_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.semcancer.2017.11.020","volume":"54","author":"S Karmakar","year":"2019","unstructured":"Karmakar S, Kaushik G, Nimmakayala R, Rachagani S, Ponnusamy MP, Batra SK. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Semin Cancer Biol. 2019;54:63\u201371. https:\/\/doi.org\/10.1016\/j.semcancer.2017.11.020.","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"2235_CR61","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1158\/0008-5472.CAN-21-4044","volume":"82","author":"CS Kubota","year":"2022","unstructured":"Kubota CS, Espenshade PJ. Targeting stearoyl-CoA desaturase in solid tumors. Cancer Res. 2022;82(9):1682\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4044.","journal-title":"Cancer Res"},{"issue":"7","key":"2235_CR62","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/cancers11070948","volume":"11","author":"Z Tracz-Gaszewska","year":"2019","unstructured":"Tracz-Gaszewska Z, Dobrzyn P. Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer. Cancers (Basel). 2019;11(7):948. https:\/\/doi.org\/10.3390\/cancers11070948.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2235_CR63","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1080\/01635581.2012.716138","volume":"64","author":"J Mac\u00e1\u0161ek","year":"2012","unstructured":"Mac\u00e1\u0161ek J, Vecka M, \u017d\u00e1k A, Urb\u00e1nek M, Krechler T, Petru\u017eelka L, et al. Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. Nutr Cancer. 2012;64(7):946\u201355. https:\/\/doi.org\/10.1080\/01635581.2012.716138.","journal-title":"Nutr Cancer"},{"key":"2235_CR64","doi-asserted-by":"publisher","unstructured":"Ye Z, Zhuo Q, Hu Q, Xu X, Mengqi Liu, Zhang Z. et al. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Redox Biol. 2021;38:101807. https:\/\/doi.org\/10.1016\/j.redox.2020.101807.","DOI":"10.1016\/j.redox.2020.101807"},{"issue":"2","key":"2235_CR65","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MPA.0000000000001737","volume":"50","author":"K Skrypek","year":"2021","unstructured":"Skrypek K, Balog S, Eriguchi Y, Asahina K. Inhibition of stearoyl-CoA desaturase induces the unfolded protein response in pancreatic tumors and suppresses their growth. Pancreas. 2021;50(2):219\u201326. https:\/\/doi.org\/10.1097\/MPA.0000000000001737.","journal-title":"Pancreas"},{"issue":"10","key":"2235_CR66","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763\u201377. https:\/\/doi.org\/10.1038\/nrc2222.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2235_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/cancers10010003","volume":"10","author":"Y Sunami","year":"2017","unstructured":"Sunami Y, Rebelo A, Kleeff J. Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells. Cancers. 2017;10(1):3.","journal-title":"Cancers"},{"issue":"7635","key":"2235_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Mart\u00edn M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41\u20135. https:\/\/doi.org\/10.1038\/nature20791.","journal-title":"Nature"},{"issue":"7546","key":"2235_CR69","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature14362","volume":"520","author":"S Schoors","year":"2015","unstructured":"Schoors S, Bruning U, Missiaen R, Queiroz KC, Borgers G, Elia I, et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature. 2015;520(7546):192\u20137. https:\/\/doi.org\/10.1038\/nature14362.","journal-title":"Nature"},{"key":"2235_CR70","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3389\/fonc.2019.01123","volume":"9","author":"X Yang","year":"2019","unstructured":"Yang X, Shao F, Shi S, Feng X, Wang W, Wang Y, et al. Prognostic impact of metabolism reprogramming markers acetyl-coa synthetase 2 phosphorylation and ketohexokinase-a expression in non-small-cell lung carcinoma. Front Oncol. 2019;9:1123. https:\/\/doi.org\/10.3389\/fonc.2019.01123.","journal-title":"Front Oncol"},{"issue":"9","key":"2235_CR71","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.21873\/anticanres.11016","volume":"36","author":"K Nishi","year":"2016","unstructured":"Nishi K, Suzuki K, Sawamoto J, Tokizawa Y, Iwase Y, Yumita N, et al. Inhibition of fatty acid synthesis induces apoptosis of human pancreatic cancer cells. Anticancer Res. 2016;36(9):4655\u201360. https:\/\/doi.org\/10.21873\/anticanres.11016.","journal-title":"Anticancer Res"},{"issue":"1","key":"2235_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/cancers10010003","volume":"10","author":"Y Sunami","year":"2017","unstructured":"Sunami Y, Rebelo A, Kleeff J. Lipid metabolism and lipid droplets in pancreatic cancer and stellate cells. Cancers (Basel). 2017;10(1):3.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2235_CR73","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1073\/pnas.97.7.3450","volume":"97","author":"FP Kuhajda","year":"2000","unstructured":"Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA. 2000;97(7):3450\u20134. https:\/\/doi.org\/10.1073\/pnas.97.7.3450.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2235_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"M Imran","year":"2019","unstructured":"Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612. https:\/\/doi.org\/10.1016\/j.biopha.2019.108612.","journal-title":"Biomed Pharmacother"},{"key":"2235_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1067652","volume":"13","author":"K Liang","year":"2022","unstructured":"Liang K, Dai JY. Progress of potential drugs targeted in lipid metabolism research. Front Pharmacol. 2022;13:1067652. https:\/\/doi.org\/10.3389\/fphar.2022.1067652.","journal-title":"Front Pharmacol"},{"key":"2235_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100797","volume":"34","author":"G Falchook","year":"2021","unstructured":"Falchook G, Infante J, Arkenau HT, Patel MR, Dean E, Borazanci E, et al. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. E Clin Med. 2021;34:100797. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100797.","journal-title":"E Clin Med"},{"issue":"11","key":"2235_CR77","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1080\/14728222.2017.1381087","volume":"21","author":"JA Menendez","year":"2017","unstructured":"Menendez JA, Lupu R. Fatty acid synthase (FASN) as a therapeutic target in breast cancer. Expert Opin Ther Targets. 2017;21(11):1001\u201316. https:\/\/doi.org\/10.1080\/14728222.2017.1381087.","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"2235_CR78","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1021\/acsptsci.3c00182","volume":"6","author":"JJ Souchek","year":"2023","unstructured":"Souchek JJ, Laliwala A, Houser L, Muraskin L, Vu Q, Mohs AM. Fatty acid synthase inhibitors enhance microtubule-stabilizing and microtubule-destabilizing drugs in taxane-resistant prostate cancer cells. ACS Pharmacol Transl Sci. 2023;6(12):1859\u201369. https:\/\/doi.org\/10.1021\/acsptsci.3c00182.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"6","key":"2235_CR79","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1158\/0008-5472.can-03-3645","volume":"64","author":"SJ Kridel","year":"2004","unstructured":"Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 2004;64(6):2070\u20135. https:\/\/doi.org\/10.1158\/0008-5472.can-03-3645.","journal-title":"Cancer Res"},{"issue":"3","key":"2235_CR80","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1592\/phco.20.4.270.34882","volume":"20","author":"AM Heck","year":"2000","unstructured":"Heck AM, Yanovski JA, Calis KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy. 2000;20(3):270\u20139. https:\/\/doi.org\/10.1592\/phco.20.4.270.34882.","journal-title":"Pharmacotherapy"},{"key":"2235_CR81","doi-asserted-by":"crossref","unstructured":"Hang S, Tsai C, Kuo C, Li Y, Cheng S. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells. 2022;78(1):85-94. 10.1007 \/s12020-022-03124-6","DOI":"10.1007\/s12020-022-03124-6"},{"key":"2235_CR82","doi-asserted-by":"publisher","first-page":"1464914","DOI":"10.3389\/fonc.2025.1464914","volume":"15","author":"Y Xu","year":"2025","unstructured":"Xu Y, Zeng J, Fu S, Liu K, Mao Y, Tao S, et al. The role of ubiquitination and deubiquitination in cancer lipid metabolism. Front Oncol. 2025;15:1464914. https:\/\/doi.org\/10.3389\/fonc.2025.1464914.","journal-title":"Front Oncol"},{"issue":"2","key":"2235_CR83","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3892\/or.2022.8469","volume":"49","author":"BC Velez","year":"2023","unstructured":"Velez BC, Petrella CP, DiSalvo KH, Cheng K, Kravtsov R, Krasniqi D, et al. Combined inhibition of ACLY and CDK4\/6 reduces cancer cell growth and invasion. Oncol Rep. 2023;49(2):32. https:\/\/doi.org\/10.3892\/or.2022.8469.","journal-title":"Oncol Rep"},{"issue":"7753","key":"2235_CR84","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1094-6","volume":"568","author":"J Wei","year":"2019","unstructured":"Wei J, Leit S, Kuai J, Therrien E, Rafi S, Harwood HJ Jr, et al. An allosteric mechanism for potent inhibition of human ATP-citrate lyase. Nature. 2019;568(7753):566\u201370. https:\/\/doi.org\/10.1038\/s41586-019-1094-6.","journal-title":"Nature"},{"issue":"5","key":"2235_CR85","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bcp.2010.12.014","volume":"81","author":"DB Jump","year":"2011","unstructured":"Jump DB, Torres-Gonzalez M, Olson LK. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem Pharmacol. 2011;81(5):649\u201360. https:\/\/doi.org\/10.1016\/j.bcp.2010.12.014.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"2235_CR86","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3748\/wjg.v20.i9.2279","volume":"20","author":"J Swierczynski","year":"2014","unstructured":"Swierczynski J, Hebanowska A, Sledzinski T. Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer. World J Gastroenterol. 2014;20(9):2279\u2013303. https:\/\/doi.org\/10.3748\/wjg.v20.i9.2279.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2235_CR87","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1158\/2159-8290.CD-21-0218","volume":"13","author":"D Thomas","year":"2023","unstructured":"Thomas D, Wu M, Nakauchi Y, Zheng M, Thompson-Peach CAL, Lim K, et al. Dysregulated lipid synthesis by oncogenic idh1 mutation is a targetable synthetic lethal vulnerability. Cancer Discov. 2023;13(2):496\u2013515. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0218.","journal-title":"Cancer Discov"},{"issue":"6","key":"2235_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011394","volume":"5","author":"D Hess","year":"2010","unstructured":"Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS ONE. 2010;5(6):e11394. https:\/\/doi.org\/10.1371\/journal.pone.0011394.","journal-title":"PLoS ONE"},{"issue":"9","key":"2235_CR89","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1258\/ebm.2012.012126","volume":"237","author":"M Nashed","year":"2012","unstructured":"Nashed M, Chisholm JW, Igal RA. Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells. Exp Biol Med (Maywood). 2012;237(9):1007\u201317. https:\/\/doi.org\/10.1258\/ebm.2012.012126.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"2235_CR90","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13062-023-00421-6","volume":"18","author":"Q Xiao","year":"2023","unstructured":"Xiao Q, Lan Z, Zhang S, Ren H, Wang S, Wang P, et al. Overexpression of ZNF488 supports pancreatic cancer cell proliferation and tumorigenesis through inhibition of ferroptosis via regulating SCD1-mediated unsaturated fatty acid metabolism. Biol Direct. 2023;18(1):77. https:\/\/doi.org\/10.1186\/s13062-023-00421-6.","journal-title":"Biol Direct"},{"issue":"1","key":"2235_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13048-024-01389-1","volume":"17","author":"J Lee","year":"2024","unstructured":"Lee J, Jang S, Im J, Han Y, Kim S, Jo H, et al. Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells. J Ovarian Res. 2024;17(1):73. https:\/\/doi.org\/10.1186\/s13048-024-01389-1.","journal-title":"J Ovarian Res"},{"issue":"1","key":"2235_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2101769","volume":"11","author":"H Luo","year":"2022","unstructured":"Luo H, Wang X, Song S, Wang Y, Dan Q, Ge H. Targeting stearoyl-coa desaturase enhances radiation induced ferroptosis and immunogenic cell death in esophageal squamous cell carcinoma. Oncoimmunology. 2022;11(1):2101769. https:\/\/doi.org\/10.1080\/2162402X.2022.2101769.","journal-title":"Oncoimmunology"},{"issue":"8","key":"2235_CR93","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/j.1349-7006.2009.01203.x","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, Sugimoto Y, et al. Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide. Cancer Sci. 2009;100(8):1556\u201362.","journal-title":"Cancer Sci"},{"issue":"15","key":"2235_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153624","volume":"20","author":"M Rossi Sebastiano","year":"2019","unstructured":"Rossi Sebastiano M, Konstantinidou G. Targeting long chain Acyl-CoA synthetases for cancer therapy. Int J Mol Sci. 2019;20(15):3624. https:\/\/doi.org\/10.3390\/ijms20153624.","journal-title":"Int J Mol Sci"},{"key":"2235_CR95","doi-asserted-by":"publisher","unstructured":"Esquea EM, Young RG, Ciraku L, Merzy J, Ahmed NN, Talarico AN. et al. ACSS2 regulates ferroptosis in an E2F1-dependent manner in breast cancer brain metastatic cells. bioRxiv. 2024: 2024.10.18.619082. https:\/\/doi.org\/10.1101\/2024.10.18.619082.","DOI":"10.1101\/2024.10.18."},{"issue":"11","key":"2235_CR96","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394.","journal-title":"Nat Med"},{"issue":"5","key":"2235_CR97","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350. https:\/\/doi.org\/10.1038\/s41591-018-0014-x.","journal-title":"Nat Med"},{"issue":"2","key":"2235_CR98","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153\u201361. https:\/\/doi.org\/10.1016\/j.cmet.2013.05.017.","journal-title":"Cell Metab"},{"issue":"1","key":"2235_CR99","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 2020;31(1):62\u201376. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.010.","journal-title":"Cell Metab"},{"issue":"15","key":"2235_CR100","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.3390\/ijms25158352","volume":"25","author":"Y Ma","year":"2024","unstructured":"Ma Y, Nenkov M, Chen Y, Ga\u00dfler N. The role of adipocytes recruited as part of tumor microenvironment in promoting colorectal cancer metastases. Int J Mol Sci. 2024;25(15):8352. https:\/\/doi.org\/10.3390\/ijms25158352.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"2235_CR101","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.7150\/thno.62378","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Sun C, Qin Z. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics. 2021;11(17):8322\u201336. https:\/\/doi.org\/10.7150\/thno.62378.","journal-title":"Theranostics"},{"issue":"5","key":"2235_CR102","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41423-026-01411-0","volume":"23","author":"YW Du","year":"2026","unstructured":"Du YW, Cai ZR, Duan XT, Li XY, Yue T, Tian T, et al. Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment. Cell Mol Immunol. 2026;23(5):457\u201370. https:\/\/doi.org\/10.1038\/s41423-026-01411-0.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"2235_CR103","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s12276-026-01650-1","volume":"58","author":"TH Kim","year":"2026","unstructured":"Kim TH, Lim SH, Lee H, Chae YC, Min DS. Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver. Exp Mol Med. 2026;58(2):366\u201381. https:\/\/doi.org\/10.1038\/s12276-026-01650-1.","journal-title":"Exp Mol Med"},{"key":"2235_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-026-01713-3","author":"J Kim","year":"2026","unstructured":"Kim J, Shin JM, Um Y, Yuan S, Lim SA. Metabolic adaptations of immunosuppressive cells in cancer: mechanisms and therapeutic targets. Exp Mol Med. 2026. https:\/\/doi.org\/10.1038\/s12276-026-01713-3.","journal-title":"Exp Mol Med"},{"key":"2235_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104878","volume":"215","author":"T Li","year":"2025","unstructured":"Li T, Bie YR, Chen SM, Shang Y, Hu PS. Fatty acid in the tumor microenvironment: Perspectives for immunotherapy. Crit Rev Oncol Hematol. 2025;215:104878. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104878.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"14","key":"2235_CR106","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41388-026-03733-9","volume":"45","author":"J Adams","year":"2026","unstructured":"Adams J, Suelzu CM, Strusi G, Stebbing J. Cancer-associated fibroblasts as key regulators of lipid metabolism in the tumour microenvironment. Oncogene. 2026;45(14):1211\u20139. https:\/\/doi.org\/10.1038\/s41388-026-03733-9.","journal-title":"Oncogene"},{"issue":"1","key":"2235_CR107","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.celrep.2014.08.056","volume":"9","author":"K Bensaad","year":"2014","unstructured":"Bensaad K, Favaro E, Lewis CA, Peck B, Lord S, Collins JM, et al. Fatty acid uptake and lipid storage induced by HIF-1\u03b1 contribute to cell growth and survival after hypoxia-reoxygenation. Cell Rep. 2014;9(1):349\u201365. https:\/\/doi.org\/10.1016\/j.celrep.2014.08.056.","journal-title":"Cell Rep"},{"issue":"7","key":"2235_CR108","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","volume":"159","author":"SA Comerford","year":"2014","unstructured":"Comerford SA, Huang Z, Du X, Wang Y, Cai L, Witkiewicz AK, et al. Acetate dependence of tumors. Cell. 2014;159(7):1591\u2013602. https:\/\/doi.org\/10.1016\/j.cell.2014.11.020.","journal-title":"Cell"},{"issue":"1","key":"2235_CR109","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2014.12.002","volume":"27","author":"ZT Schug","year":"2015","unstructured":"Schug ZT, Peck B, Jones DT, Zhang Q, Grosskurth S, Alam IS, et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell. 2015;27(1):57\u201371. https:\/\/doi.org\/10.1016\/j.ccell.2014.12.002.","journal-title":"Cancer Cell"},{"issue":"4","key":"2235_CR110","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13(4):227\u201332. https:\/\/doi.org\/10.1038\/nrc3483.","journal-title":"Nat Rev Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02235-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02235-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02235-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:19:28Z","timestamp":1785521968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02235-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2235"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02235-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors have consented to participate.","order":1,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have consented to the publication of the text.","order":2,"name":"Ethics","label":"Consent to publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"282"}}